Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

194 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Protein Interactions during the Flavivirus and Hepacivirus Life Cycle.
Gerold G, Bruening J, Weigel B, Pietschmann T. Gerold G, et al. Among authors: weigel b. Mol Cell Proteomics. 2017 Apr;16(4 suppl 1):S75-S91. doi: 10.1074/mcp.R116.065649. Epub 2017 Jan 11. Mol Cell Proteomics. 2017. PMID: 28077444 Free PMC article. Review.
Predicting genotoxicity of viral vectors for stem cell gene therapy using gene expression-based machine learning.
Schwarzer A, Talbot SR, Selich A, Morgan M, Schott JW, Dittrich-Breiholz O, Bastone AL, Weigel B, Ha TC, Dziadek V, Gijsbers R, Thrasher AJ, Staal FJT, Gaspar HB, Modlich U, Schambach A, Rothe M. Schwarzer A, et al. Among authors: weigel b. Mol Ther. 2021 Dec 1;29(12):3383-3397. doi: 10.1016/j.ymthe.2021.06.017. Epub 2021 Jun 24. Mol Ther. 2021. PMID: 34174440 Free PMC article.
A phase 1/2 study of pepinemab in children, adolescents, or young adults with recurrent or refractory solid tumors: A children's oncology group consortium report (ADVL1614).
Greengard E, Williams R, Moriarity B, Liu X, Minard CG, Reid JM, Fisher T, Evans E, Pastore DR, Zauderer M, Voss S, Fox E, Weigel BJ. Greengard E, et al. Among authors: weigel bj. Pediatr Blood Cancer. 2024 Jun;71(6):e30938. doi: 10.1002/pbc.30938. Epub 2024 Mar 23. Pediatr Blood Cancer. 2024. PMID: 38520670 Clinical Trial.
A phase 1 trial utilizing a pharmacokinetic endpoint to determine the optimal dose of ramucirumab in children and adolescents with relapsed or refractory solid tumors, including central nervous system tumors.
Pilbeam KL, Pradhan K, Croop J, Minard CG, Liu X, Voss SD, Isikwei E, Berg SL, Reid JM, Fox E, Weigel BJ. Pilbeam KL, et al. Among authors: weigel bj. Pediatr Blood Cancer. 2024 Mar;71(3):e30817. doi: 10.1002/pbc.30817. Epub 2024 Jan 8. Pediatr Blood Cancer. 2024. PMID: 38189770 Clinical Trial.
194 results